Insulin-Like Growth Factor-1 Receptor Signaling Increases the Invasive Potential of Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer Cells via Src-Focal Adhesion Kinase and Forkhead Box Protein M1

Resistance to the human epidermal growth factor receptor (HER2)–targeted antibody trastuzumab is a major clinical concern in the treatment of HER2-positive metastatic breast cancer. Increased expression or signaling from the insulin-like growth factor-1 receptor (IGF-1R) has been reported to be asso...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Pharmacol
Asıl Yazarlar: Sanabria-Figueroa, Eduardo, Donnelly, Siobhan M., Foy, Kevin C., Buss, Meghan C., Castellino, Robert C., Paplomata, Elisavet, Taliaferro-Smith, Latonia, Kaumaya, Pravin T.P., Nahta, Rita
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The American Society for Pharmacology and Experimental Therapeutics 2015
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293451/
https://ncbi.nlm.nih.gov/pubmed/25391374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.114.095380
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller